SCHEMBL256668

SCHEMBL256668

CC/C=C/c1c[nH]c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.56
KMT2A Q03164 9/20 0.56
RAB9A P51151 6/20 0.56
NPC1 O15118 5/20 0.56
USP2 O75604 3/20 0.56
APOBEC3A P31941 2/20 0.56
APOBEC3G Q9HC16 2/20 0.56
CYP2A6 P11509 1/20 0.55
IMPDH2 P12268 1/20 0.55
MAPT P10636 7/20 0.53
LMNA P02545 4/20 0.53
KDM4E B2RXH2 5/20 0.50
HPGD P15428 4/20 0.50
ALDH1A1 P00352 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
HTT P42858 2/20 0.50
ATM Q13315 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159319 1.00 MEN1 (0.56) MEN1KMT2ARAB9ANPC1USP2
SCHEMBL20309510 0.90 MEN1 (0.54) MEN1KMT2ARAB9ANPC1USP2
SCHEMBL28550147 0.88 MEN1 (0.55) MEN1KMT2ARAB9ANPC1USP2
SCHEMBL3697106 0.83 KMT2A (0.51) MEN1KMT2ARAB9ANPC1USP2
SCHEMBL3697104 0.83 KMT2A (0.51) MEN1KMT2ARAB9ANPC1USP2
SCHEMBL3621033 0.83 CYP2A6 (0.60) MEN1KMT2ARAB9ANPC1USP2
SCHEMBL10489040 0.82 CYP2A6 (0.69) MEN1KMT2ARAB9ANPC1USP2
SCHEMBL27854157 0.82 KMT2A (0.50) MEN1KMT2ARAB9ANPC1USP2
SCHEMBL12425727 0.82 CYP2A6 (0.55) MEN1KMT2ARAB9ANPC1USP2
SCHEMBL3435669 0.82 CYP2A6 (0.55) MEN1KMT2ARAB9ANPC1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones BAYER CROPSCIENCE AG (DE) 2012-06-21 US disclosed
WO-2012028578-A1 SUBSTITUTED FUSED PYRIMIDINONES AND DIHYDROPYRIMIDINONES BAYER CROPSCIENCE AG (DE) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157306-A1 Substituted Fused Pyrimidinones and Dihydropyrimidinones DHPS, FDPS, DPYD MEN1 3414/4885KMT2A 3719/4885RAB9A 783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.